Japara Healthcare Ltd (ASX: JHC) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Japara Healthcare Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

Should you invest $1,000 in right now?

Before you consider , you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

Japara Healthcare Ltd (ASX: JHC)
Latest News

bull market encapsulated by bull running up a rising stock market price
Share Market News

ASX 200 rises, Temple & Webster surges, Japara soars

The ASX 200 rose today. Temple & Webster shares went up after reporting its result.

Read more »

white arrows symbolising growth
Share Gainers

Why BlueScope, Japara, OZ Minerals, & Temple & Webster are storming higher

Here's why these ASX shares are rising strongly today...

Read more »

golden hawk flying high in the sky
Healthcare Shares

Japara (ASX:JHC) share price soars 18% on takeover news

Japara's board is recommending shareholders vote in favour of a takeover offer.

Read more »

ASX share price broker upgrade ASX lithium shares buy represented by upgrade button on computer keyboard
Broker Notes

Top brokers just upgraded these ASX shares to “buy”

The market hit a new record high on the first trading day of the week and two ASX shares are…

Read more »

The last piece of the jigsaw being fitted, indicating good news for a share price on merger or acquisition
Mergers & Acquisitions

Japara (ASX:JHC) share price shoots higher on second takeover offer

Is a bidding war brewing for this aged care provider?

Read more »

Older man getting blood pressure checked with nurse indicating healthcare aged care
52-Week Highs

Why the Japara (ASX:JHC) share price just hit a 52-week high

Calvary Health Care has increased its bid for the aged care provider.

Read more »

an elderly woman wearing boxing gloves raises one toward her face in a boxing pose while looking towards the camera with grey hair and spectacles on.
Share Gainers

This beaten-up sector has some of the top performing ASX shares this year

ASX aged care shares have emerged as top performers this year after slumping as much as 80% between 2016 and…

Read more »

asx share price swing represented by old lady on swing
Healthcare Shares

ASX aged care shares boosted after 2021 Federal Budget

ASX shares in the aged sector, like Estia Health Ltd (ASX: EHE), received a boost today after a big cash…

Read more »

Dividend Payment History Data provided by Morningstar.

Data provided by Morningstar.
Ex-Date Amount Franking Type Payable
26 Mar 2020 $0.0200 50.00% Interim 30 Apr 2020
26 Sep 2019 $0.0336 50.00% Final 30 Oct 2019
27 Mar 2019 $0.0280 0.00% Interim 30 Apr 2019
27 Sep 2018 $0.0376 50.00% Final 30 Oct 2018
27 Mar 2018 $0.0400 65.00% Interim 30 Apr 2018
28 Sep 2017 $0.0576 69.97% Final 30 Oct 2017
27 Mar 2017 $0.0550 100.00% Interim 28 Apr 2017
27 Sep 2016 $0.0575 100.00% Final 31 Oct 2016
07 Apr 2016 $0.0575 100.00% Interim 16 May 2016
07 Oct 2015 $0.0550 100.00% 30 Oct 2015
07 Apr 2015 $0.0550 0.00% 30 Apr 2015

JHC ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
YesNo

About Japara Healthcare Ltd

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
25 Oct 2021 Christopher (Chris) Price Buy 1 $2,016,000
Conversion of securities. Estimated valuation
25 Oct 2021 Christopher (Chris) Price Exercise 1 $2,016,000
Conversion of securities. Estimated valuation

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mrs Linda Bardo Nicholls Non-Executive ChairmanNon-Executive Director Mar 2014
Ms Nicholls AO is a senior executive and company director with more than 30 years' experience across Australia, New Zealand and the United States. In addition to her current Australian listed company directorships, she is Chairperson of Melbourne Health and a Member of the Museums Board of Victoria. Previously, she has held the position of Chairman at some of Australia's most wellregarded companies including Healthscope, Australia Post and Yarra Trams. Other current Australian listed company directorships: Medibank Private (appointed 31 March 2014), Inghams Group (appointed 7 October
2016)
Mr David Paul Blight Non-Executive Director Mar 2014
Mr Blight is the co-founder and CEO of ARA Australia, the Australian business of the Singapore based ARA Group. ARA is an Asia Pacific real estate investment management firm with over $50 billion in funds under management. He is Chairman of IP Generation and IP Generation Fund Management and is a Non-Executive Director of Lifestyle Communities. His previous roles include Vice Chairman of ING Real Estate and Global Chairman and CEO of ING Real Estate Investment Management based in The Netherlands. He has also held senior executive positions with Armstrong Jones, Mirvac Group and APN Property Group. He has more than 30 years' experience in the real estate industry, across all major global markets and property sectors. Other current Australian listed company directorships: Lifestyle Communities (appointed 15 June 2018)
Dr Leanne Rowe Non-Executive Director Jul 2019
Ms Rowe AM is a Clinical Professor and Medical Practitioner with over 30 years of clinical experience in the public and private health systems across acute care, aged care, mental health and community health. She is Chairman of Nexus hospitals and in addition to her current Australian listed company directorships is a Non-Executive Director of the Medical Indemnity Protection Society and MIPS Insurance. Previously she was Chairman of the Royal Australian College of General Practitioners and a Non-Executive Director of I-MED Radiology Network, Medibank Private, GMHBA, Australian Health Management, Barwon Health and Beyond Blue. She is a former Deputy Chancellor of Monash University and has been awarded a Doctor of Laws (honoris causa) for her services. She has also received a Member of the Order of Australia for her services to medicine and is a Fellow of the Royal Australian College of General Practitioners and the Australian Institute of Company Directors. Other current Australian listed company directorships: Doctor Care Anywhere Group (appointed 17 September 2020), Australian Clinical Labs (appointed 28 April 2021)
Ms JoAnne Maree Stephenson Non-Executive Director Sep 2015
Ms Stephenson has over 25 years of extensive experience in financial services having been a partner with KPMG and has key strengths in finance, accounting, risk management and governance. She is Acting Chairman of Myer Holdings and a Non-Executive Director of Challenger. She is also Chair of the Major Transport Infrastructure Board (Victoria). Other current Australian listed company directorships: Challenger (appointed 8 October 2012), Myer Holdings (appointed 28 November 2016)
Mr Christopher (Chris) Price Chief Executive OfficerManaging Director Jul 2015
Mr Price has over 25 years of experience in the financial services, professional services and manufacturing sectors. Prior to joining the Company, he was Managing Director of former ASX listed professional services firm Crowe Horwath Australasia Limited, having previously served as its Chief Financial Officer for seven years. He is a member of Chartered Accountants Australia and New Zealand. He has not held any other directorships of listed companies in the last three years
Mr Bruce Craig Paterson Company Secretary Dec 2015
-
Anthony Rice CFO and Chief investment Officer (CFO/CIO)
-
Lindon Le Griffon Chief Operations Officer (COO)
-
Bruce Craig Paterson Company Secretary
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
Citicorp Nominees Pty Limited 31,156,876 11.66%
Cs Third Nominees Pty Limited (HSBC Cust Nom Au Ltd 12 A/C) 24,649,373 9.22%
HSBC Custody Nominees (Australia) Limited 23,486,248 8.79%
The Trust Company (Australia) Limited (A/C 4) 19,361,813 7.24%
Ashens Properties Pty Ltd (Sudholz Family Discretionary Trust A/C) 15,127,179 5.66%
Moelis Australia Asset Management Ltd (Moelis Aus Partners A/C) 14,984,821 5.61%
J P Morgan Nominees Australia Pty Limited 14,875,902 5.57%
HSBC Custody Nominees (Australia) Limited A/C 2 8,283,401 3.10%
Sudsie Pty Ltd 5,858,333 2.19%
National Nominees Limited 5,382,305 2.01%
Cs Fourth Nominees Pty Limited (HSBC Cust Nom Au Ltd 11 A/C) 3,732,837 1.40%
Brispot Nominees Pty Ltd (House Head Nominee A/C) 3,325,381 1.24%
BNP Paribas Nominees Pty Ltd Hub24 Custodial Serv Ltd (Drp A/C) 3,050,473 1.14%
Neweconomy Com Au Nominees Pty Limited (900 Account) 2,738,549 1.02%
Cs Third Nominees Pty Limited (HSBC Cust Nom Au Ltd 13 A/C) 2,565,850 0.96%
Manken (Manken Family Super A/C) 2,310,000 0.86%
BNP Paribas Noms Pty Ltd (Drp) 2,232,590 0.84%
Morgan Stanley Australia Securities (Nominee) Pty Limited (No 1 Account) 1,842,439 0.69%
Bundarra Trading Company Pty Ltd (Thomas Emery Kennedy A/C) 1,700,000 0.64%
Sep Super Pty Ltd (Sep Super Fund A/C) 1,311,480 0.49%

Profile

since

Note